Skip to main content
. 2022 Feb 25;126(12):1795–1805. doi: 10.1038/s41416-022-01744-3

Fig. 1. Schematic illustration of the study design.

Fig. 1

LCBM non-small cell lung cancer (NSCLC) brain metastasis (BM), LM single organ liver metastasis, BoM single organ bone metastasis, ALC advanced NSCLC without distant organ metastasis, ELC early-stage NSCLC, PBT primary brain tumours, HG healthy group. Corresponding non-tumour is matched with patient of NSCLC without BM.